Congruence Autoinjector with Injection Pause(TM) Technology

The Congruence Autoinjector is a next generation disposable autoinjector platform, designed for self-injection applications. It utilizes a proprietary compressed-gas power source, making it compact yet powerful for delivery of high-dose formulations that are of higher viscosity and/or larger volume. It also incorporates novel usability features to mitigate well-known autoinjector user errors, such as Injection Pause(TM) technology which addresses premature removal from the skin prior to end of dose. The Congruence Autoinjector has significant advantages over currently available legacy devices, enabling it to meet the current and future needs of patients and the biopharma market. It offers: ENHANCED USABILITY, and in particular addresses the perennial issue of premature removal from skin HIGH FORCE CAPABILITY to rapidly deliver larger volume (2mL and greater) and/or higher viscosity (30 to 100+cP) drugs and/or through fine injection needle GREATER VERSATILITY - suitable not just for higher viscosities and larger volumes, but also standard viscosities and volumes EASIER CUSTOMIZATION for faster, lower risk device development INCORPORATES STANDARD PRIMARY CONTAINERS, such as standard glass or polymer pre-fillable syringes SUSTAINABILITY ALIGNED, through compact size reducing materials, supply chain costs, and minimizing drug waste with Injection Pause feature APPLICATION AREAS The Congruence Autoinjector platform is designed to have broad suitability across a wide range of self-injection drugs (volume, viscosity) and broad patient populations (autoimmune, oncology, neuro, dermatology, etc.). The platform's ability to deliver viscous drugs and/or larger volume doses means it can be used for delivering high-strength biologic formulations. As the platform can be easily customized, it is suitable for use across the drug lifecycle (including during drug development) and/or across multiple formulations or drugs in a portfolio. KEY FEATURES The Congruence A...